Marie Sébert

11PUBLICATIONS
82CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumoursPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 26, 2026
Ivosidenib monotherapy in IDH1 mutated myelodysplastic neoplasm/syndrome.

|Jul 08, 2026
Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemia.

|Mar 25, 2026
Predisposition to ALL and Solid Tumors Rather Than Bone Marrow Failure in FANCM-Associated Fanconi Anemia.

Francesco Pegoraro, Lise Larcher, Rathana Kim

|Jun 25, 2025
IPSS-M risk and specific sex-associated somatic mutations predict response to ESA therapy in LR-MDS: building a new score.

Marco G Raddi, Sophie Park, Michaela Fontenay

|Apr 18, 2025
Prognostic significance of monocytic-like phenotype in patients with AML treated with venetoclax and azacytidine.

Lin-Pierre Zhao, Typhaine Dumas-Rivero, Lauren Barette

|May 30, 2024
Targeting a lineage-specific PI3Kɣ-Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader molecule.

Lois M Kelly, Justine C Rutter, Kevin H Lin

Pageof 2

Frequent Collaborators

10 joint publications

Lionel Adès

6 joint publications

Emmanuelle Clappier

5 joint publications

Lise Larcher

5 joint publications

Raphaël Itzykson